BIRC3 and liver cancer: However, we have also observed that when cIAP2 expression was downregulated via various means including cIAP2 knockdown, inhibition of Akt and HBV replication, the sorafenib resistance has only been partially overcome, indicating that other factors may also be involved in sorafenib resistance in HBV infected liver cancer.